{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:14:21Z","timestamp":1791389661199,"version":"4.3.3"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.canep.2025.102946","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:52:48Z","timestamp":1761364368000},"page":"102946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Prevalence of vaccine-induced immunity to hepatitis B in cancer patients: A 13-year analysis in a quaternary oncological center"],"prefix":"10.1016","volume":"99","author":[{"given":"Mariana Cavalheiro","family":"Magri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vict\u00f3ria Gon\u00e7alves","family":"de Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7952-7671","authenticated-orcid":false,"given":"Marina Rossi de Camargo","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora Bignotto Rosane","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Manoel","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1tima Mitiko","family":"Tengan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edson","family":"Abdala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2025.102946_bib1","unstructured":"World Health Organization. Global Hepatitis Report 2024. Accessed January 30, 2025. \u3008https:\/\/www.who.int\/publications\/i\/item\/9789240091672\u3009."},{"key":"10.1016\/j.canep.2025.102946_bib2","unstructured":"Minist\u00e9rio da Sa\u00fade. Boletim epidemiol\u00f3gico - hepatites virais 2025 - Epidemiological report - viral hepatitis 2025. Bras\u00edlia, DF: Minist\u00e9rio da Sa\u00fade, 2025. Accessed September 24, 2025. \u3008https:\/\/www.gov.br\/saude\/pt-br\/centrais-de-conteudo\/publicacoes\/boletins\/epidemiologicos\/especiais\/2025\/boletim-epidemiologico-de-hepatites-virais.pdf\u3009."},{"issue":"10","key":"10.1016\/j.canep.2025.102946_bib3","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3748\/wjg.v30.i10.1295","article-title":"Overview of the immunological mechanisms in hepatitis b virus reactivation: implications for disease progression and management strategies","volume":"30","author":"Ma","year":"2024","journal-title":"World J. Gastroenterol."},{"issue":"26","key":"10.1016\/j.canep.2025.102946_bib4","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.3748\/wjg.v30.i26.3193","article-title":"Reactivation of hepatitis b virus infection - an important aspect of multifaceted problem","volume":"30","author":"Morozov","year":"2024","journal-title":"World J. Gastroenterol."},{"issue":"21","key":"10.1016\/j.canep.2025.102946_bib5","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.12998\/wjcc.v9.i21.5769","article-title":"Prevention of hepatitis b reactivation in patients requiring chemotherapy and immunosuppressive therapy","volume":"9","author":"Shih","year":"2021","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.canep.2025.102946_bib6","series-title":"Global Cancer Observatory: Cancer today","author":"Ferlay","year":"2025"},{"issue":"12","key":"10.1016\/j.canep.2025.102946_bib7","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.3390\/vaccines11121862","article-title":"HBV vaccines: advances and development","volume":"11","author":"Mahmood","year":"2023","journal-title":"Vaccines"},{"issue":"12 2","key":"10.1016\/j.canep.2025.102946_bib8","doi-asserted-by":"crossref","first-page":"S343","DOI":"10.1093\/infdis\/jiaa668","article-title":"Hepatitis B vaccines","volume":"224","author":"Pattyn","year":"2021","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.canep.2025.102946_bib9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/vaccines11030597","article-title":"Prevalence, risk factors and vaccine response against hepatitis B in people aged 50 years or older","volume":"11","author":"da Cunha Rosa","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.canep.2025.102946_bib10","doi-asserted-by":"crossref","DOI":"10.1590\/1518-8345.6107.3765","article-title":"Serological and vaccine evaluation for hepatitis b among community health workers","volume":"31","author":"Amaral","year":"2023","journal-title":"Rev. Lat. Am. Enferm."},{"key":"10.1016\/j.canep.2025.102946_bib11","unstructured":"Minist\u00e9rio da Sa\u00fade. Protocolo cl\u00ednico e diretrizes terap\u00eauticas para hepatite B e coinfec\u00e7\u00f5es - Clinical protocol and therapeutic guidelines for hepatitis B and coinfections. Bras\u00edlia, DF: Minist\u00e9rio da Sa\u00fade, 2023. Accessed April 23, 2025. \u3008http:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/protocolo_clinico_diretrizes_terapeuticas_hepbdigital.pdf\u3009."},{"key":"10.1016\/j.canep.2025.102946_bib12","series-title":"no","article-title":"Prevalence and trends in hepatitis B virus infection in the United States, 2015\u20132018","volume":"361","author":"Kruszon-Moran","year":"2020"},{"issue":"3","key":"10.1016\/j.canep.2025.102946_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.htct.2018.11.008","article-title":"Hepatitis b virus infection among oncohematologic disease patients in central Brazil: prevalence, risk factors and immunization","volume":"41","author":"Pessoni","year":"2019","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"10.1016\/j.canep.2025.102946_bib14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jcv.2013.07.003","article-title":"High non-responsiveness of males and the elderly to standard hepatitis b vaccination among a large cohort of healthy employees","volume":"58","author":"Vermeiren","year":"2013","journal-title":"J. Clin. Virol."},{"issue":"3","key":"10.1016\/j.canep.2025.102946_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jmv.25610","article-title":"Ethnicity and response to primary three-dose hepatitis b vaccination in employees in the Netherlands, 1983 through 2017","volume":"92","author":"Koc","year":"2020","journal-title":"J. Med Virol."},{"issue":"11","key":"10.1016\/j.canep.2025.102946_bib16","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/j.immuni.2023.10.008","article-title":"Sex hormone signaling and regulation of immune function","volume":"56","author":"Hoffmann","year":"2023","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.canep.2025.102946_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/diseases8020010","article-title":"Disparities in hepatitis b vaccine coverage by race\/ethnicity: The National health and nutrition examination survey (NHANES) 2015-2016","volume":"8","author":"Bhuiyan","year":"2020","journal-title":"Diseases"},{"issue":"9","key":"10.1016\/j.canep.2025.102946_bib18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.6004\/jnccn.2024.0056","article-title":"Prevention and treatment of cancer-related infections, version 3.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Baden","year":"2024","journal-title":"J. Natl. Compr. Canc Netw."},{"issue":"6","key":"10.1016\/j.canep.2025.102946_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3747\/co.v17i6.653","article-title":"Screening for hepatitis b surface antigen before chemotherapy: current practice and opportunities for improvement","volume":"17","author":"Lee","year":"2010","journal-title":"Curr. Oncol."},{"issue":"1","key":"10.1016\/j.canep.2025.102946_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10620-017-4850-1","article-title":"Practice patterns in hepatitis b virus screening before cancer chemotherapy in a major US hospital network","volume":"63","author":"Kwak","year":"2018","journal-title":"Dig. Dis. Sci."},{"issue":"5","key":"10.1016\/j.canep.2025.102946_bib21","doi-asserted-by":"crossref","first-page":"552","DOI":"10.5152\/tjg.2023.22297","article-title":"Electronic alert system significantly increases HBV screening rates before immunosuppressive treatments","volume":"34","author":"K\u00f6ksal","year":"2023","journal-title":"Turk. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.canep.2025.102946_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116978","article-title":"The compliance of doctors with viral hepatitis b screening and antiviral prophylaxis in cancer patients receiving cytotoxic chemotherapy using a hospital-based screening reminder system","volume":"10","author":"Sun","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.canep.2025.102946_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejca.2022.05.029","article-title":"Booster doses of COVID-19 vaccines for patients with haematological and solid cancer: a systematic review and individual patient data meta-analysis","volume":"172","author":"Mai","year":"2022","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.canep.2025.102946_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13045-022-01233-3","article-title":"Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis","volume":"15","author":"Sakuraba","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canep.2025.102946_bib25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-cellbio-100616-060718","article-title":"Sex and gender differences in the outcomes of vaccination over the life course","volume":"33","author":"Flanagan","year":"2017","journal-title":"Annu Rev. Cell Dev. Biol."},{"key":"10.1016\/j.canep.2025.102946_bib26","unstructured":"UK Health Security Agency. Hepatitis B: the green book, chapter 18. 2024. Accessed February 03, 2025. \u3008https:\/\/www.gov.uk\/government\/publications\/hepatitis-b-the-green-book-chapter-18\u3009."},{"issue":"7","key":"10.1016\/j.canep.2025.102946_bib27","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1080\/21645515.2015.1039758","article-title":"Characterization of an age-response relationship to GSK's recombinant hepatitis b vaccine in healthy adults: an integrated analysis","volume":"11","author":"Van Der Meeren","year":"2015","journal-title":"Hum. Vaccin Immunother."},{"key":"10.1016\/j.canep.2025.102946_bib28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3389\/fimmu.2020.00717","article-title":"Vaccines to prevent infectious diseases in the older population: immunological challenges and future perspectives","volume":"11","author":"Wagner","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canep.2025.102946_bib29","series-title":"Hepatitis B vaccines: WHO position paper \u2013 July 2017. Weekly Epidemiological Record 2017","first-page":"369","author":"World Health Organization","year":"2017"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782125002061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782125002061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T07:37:35Z","timestamp":1780126655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782125002061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":29,"alternative-id":["S1877782125002061"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2025.102946","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of vaccine-induced immunity to hepatitis B in cancer patients: A 13-year analysis in a quaternary oncological center","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2025.102946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102946"}}